460470.KQ
IVIM Technology
KOE · Healthcare · Medical - Specialties · KR
KRW 2,730.00
−3.87%Year over year
Reported trailing growth
- Revenue
- +85.9%
- EBITDA
- -26.5%
- EBIT
- +31.8%
- EPS
- +39.6%
- Free cash flow
- +38.5%
- Operating cash flow
- +62.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +48.4%
- EBITDA
- +5.8%
- EBIT
- +3.6%
- Net income
- +5.0%
- EPS
- +10.1%
- Free cash flow
- +11.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026